FDA Warning Letter: Innoveix Pharmaceuticals Inc
Compounding Pharmacy/Adulterated Drug Products. Issued by FDA Office of Pharmaceutical Quality Operations, Division II on 2022-01-26.
FDA Office of Pharmaceutical Quality Operations, Division II